Depo-medrol Injection, Suspension
Product Images NDC 0009-0306

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Depo-medrol (NDC 0009-0306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Depo Medrol 01)

Chemical structure diagram of the active ingredient in Depo-Medrol, showing its molecular framework with carbon, hydrogen, and oxygen atoms represented in a skeletal formula.*

FDA Label Image

Logo (Depo Medrol 02)

FDA Label Image

Principal Display Panel (100 mg/5 mL Vial Label)

Label for Depo-Medrol injectable suspension, USP, containing methylprednisolone acetate. The vial is a 5 mL multidose with a total strength of 100 mg per 5 mL (20 mg/mL). It is distributed by Pharmacia & Upjohn Company, a division of Pfizer Inc. The label notes use for intramuscular, intrasynovial, and soft tissue injection only and includes preservative information and usage instructions.*

FDA Label Image

Principal Display Panel (100 mg/5 mL Vial Carton)

Packaging label for Depo-Medrol 100 mg/5 mL (20 mg/mL) methylprednisolone acetate injectable suspension in a 5 mL multidose vial. The label includes storage instructions, active ingredient concentration, and cautions for intramuscular, intra-synovial, and soft tissue injection use only, not for IV use. Distributed by Pharmacia & Upjohn Company, Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (200 mg/5 mL Vial Label)

Label for Depo-Medrol injectable suspension containing methylprednisolone acetate. The 5 mL multidose vial has a strength of 200 mg/5 mL (40 mg/mL). The label indicates it is for intramuscular, intra-synovial, and soft tissue injection only, not for IV use. Distributed by Pharmacia & Upjohn Company, Pfizer division, New York, NY.*

FDA Label Image

Principal Display Panel (200 mg/5 mL Vial Package)

Depo-Medrol 200 mg/5 mL (40 mg/mL) injectable suspension carton label for 25 five mL multidose vials. The label includes the active ingredient methylprednisolone acetate, instructions for intramuscular, intra-articular, and soft tissue injection only, and a note that it is not for IV use. It also states that benzyl alcohol is used as a preservative. The product is distributed by Pharmacia & Upjohn Company, a division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (400 mg/5 mL Vial Label)

Depo-Medrol 80 mg/mL methylprednisolone acetate injectable suspension label for a 5 mL multidose vial. The label indicates a total drug amount of 400 mg per 5 mL, with dosing instructions stating use for intramuscular, intrasynovial, and soft tissue injections only, not for intravenous use. The product contains benzyl alcohol as a preservative. Distributed by Pharmacia & Upjohn Co, a Pfizer division.*

FDA Label Image

Principal Display Panel (400 mg/5 mL Vial Carton)

Packaging label for Depo-Medrol 400 mg/5 mL (80 mg/mL) injectable suspension in a 5 mL multidose vial. The product contains methylprednisolone acetate and benzyl alcohol as a preservative. It is for intramuscular, intrasynovial, and soft tissue injection only and is not for IV use. Distributed by Pharmacia & Upjohn Company, a division of Pfizer Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.